Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 6
Submit an article Journal homepage
290
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis

Fiona HeDivision of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA;
,
Hans-Peter HornyInstitute of Pathology, Ludwig-Maximilians-University, Munich, Germany
,
Jamie BooneDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA;
,
Ahmad RazaDivision of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA;
,
Megan GriffithDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA;
,
Peter HurleyDivision of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA;
,
Michelle DolanDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA;
,
Zuzan CayciDepartment of Radiology, University of Minnesota, Minneapolis, MN, USA;
,
Michael A. LindenDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA;
,
Robert McKennaDepartment of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN, USA;
&
Celalettin UstunDivision of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA; Correspondence[email protected]
 show all
Pages 1515-1517 | Received 05 Sep 2016, Accepted 14 Oct 2016, Published online: 03 Nov 2016

References

  • Georgin-Lavialle S, Aguilar C, Guieze R, et al. Mast cell sarcoma: a rare and aggressive entity – report of two cases and review of the literature. J Clin Oncol. 2013;31:e90–e97.
  • Horny HP, Parwaresch MR, Kaiserling E, et al. Mast cell sarcoma of the larynx. J Clin Pathol. 1986;39:596–602.
  • Brcic L, Vuletic LB, Stepan J, et al. Mast-cell sarcoma of the tibia. J Clin Pathol. 2007;60:424–425.
  • Bugalia A, Abraham A, Balasubramanian P, et al. Mast cell sarcoma of the small intestine: a case report. J Clin Pathol. 2011;64:1035–1037.
  • Schwaab J, Horny HP, Jonescheit J, et al. Mast cell sarcoma mimicking metastatic colon carcinoma. Ann Hematol. 2014;93:1067–1069.
  • Monnier J, Georgin-Lavialle S, Canioni D, et al. Mast cell sarcoma: new cases and literature review. Oncotarget. 2016. [Epub ahead of print].
  • Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603–625.
  • Horny HP, Sotlar K, Valent P. Eosinophil, basophil, and mast cell infiltrates in the bone marrow: crossing the boundaries of diagnosis. J Hematopathol. 2011;4:101–111.
  • Forsberg LA, Rasi C, Malmqvist N, et al. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer. Nat Genet. 2014;46:624–628.
  • Steensma DP, Bejar R, Jaiswal S, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126:9–16.
  • Horny HP, Sotlar K, Valent P. Mastocytosis immunophenotypical features of the transformed mast cells are unique among hematopoietic cells. Immunol Allergy Clin N Am. 2014;34:315.
  • Ryan RJ, Akin C, Castells M, et al. Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol. 2013;26:533–543.
  • Sotlar K, Cerny-Reiterer S, Petat-Dutter K, et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol. 2011;24:585–595.
  • Ma HB, Xu X, Liu WP, et al. Successful treatment of mast cell sarcoma of the uterus with imatinib. Int J Hematol. 2011;94:491–494.
  • Sotlar K, Horny HP, Lebherz J, et al. Association of bone marrow mastocytosis with extremely immature extramedullary mast cell sarcoma. Pathologe. 1997;18:252–256.
  • Krauth MT, Fodinger M, Rebuzzi L, et al. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. Haematologica. 2007;92:e126–e129.
  • Alvarez-Twose I, Martinez-Barranco P, Gotlib J, et al. Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia. Leukemia. 2016;30:1753–1756.
  • Gotlib J, Kluin-Nelemans HC, George TI, et al. Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med. 2016;374:2530–2541.
  • Ustun C, Reiter A, Scott BL, et al. Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol. 2014;32:3264–3274.
  • Ustun C, Arock M, Kluin-Nelemans HC, et al. Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice. Haematologica. 2016;101:1133–1143.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.